Pimavanserin as treatment for Parkinson's disease psychosis

Lancet. 2014 Feb 8;383(9916):494-6. doi: 10.1016/S0140-6736(13)62157-1. Epub 2013 Nov 1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Antipsychotic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Parkinson Disease / psychology*
  • Piperidines / therapeutic use*
  • Psychotic Disorders / drug therapy*
  • Serotonin 5-HT2 Receptor Agonists / therapeutic use*
  • Urea / analogs & derivatives*
  • Urea / therapeutic use

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents
  • Piperidines
  • Serotonin 5-HT2 Receptor Agonists
  • Urea
  • pimavanserin